Clinical Trial Experiences of Patients 10-17-2014 UPDATE
BioMarin is currently seeking patients for a Phase 3 clinical trial in Late Onset Pompe Disease.
MEDIC ALERT BROCHURE
Amicus Therapeutics Announces First Patient in Phase 2 Study for Pompe Disease

SARI
BartJan

Related Articles

Survey
UNITED STATES POMPE COMMUNITY UPDATE, AUGUST 1, 2014
Genzyme Receives Label Expansion for Lumizyme® (alglucosidase alfa) in the United States for the treatment of Pompe Disease
Expression of Hope 2014
Share your thoughts by participating in an interview
Amicus Therapeutics Strengthens Biologics Business Strategy
Amicus Therapeutics Announces Positive Pompe Program Updates
March 19, 2012 Community Update for Pompe Families in the United States who Utilize Myozyme® (alglucosidase alfa) Produced at the 160 L Manufacturing Scale
March 19, 2012 Community Update for Pompe Families in the United States who Utilize Myozyme® (alglucosidase alfa) Produced at the 160 L Manufacturing Scale
ADVANCE Study Fact Sheet
ADVANCE Study Fact Sheet
Community Update for Pompe Families in the United States who Utilize Myozyme®
AMICUS POMPE COMMUNITY UPDATE
Amicus Therapeutics Announces FDA Agreement to Commence Phase 2 Study of AT2220 Co-administered with Enzyme Replacement Therapy for Pompe Disease
Amicus Therapeutics Announces FDA Agreement to Commence Phase 2 Study of AT2220 Co-administered with Enzyme Replacement Therapy for Pompe Disease
Sanofi-aventis to Acquire Genzyme
Sanofi-aventis to Acquire Genzyme
POMPE in COMMON
United States Pompe Program Update, August 9, 2010
United States Pompe Program Update, May 25, 2010
LUMIZYME APPROVAL
US Pompe Program Update – December 3, 2009
US Pompe Program Update – December 3, 2009
US Pompe Program Update - November 16, 2009
Pompe Program Update ? May 22, 2009
HOME ADAPTIONS FOR SAFETY AND ACCESSIBILITY
Pompe Program Update March 2, 2009
Genzyme Receives Complete Response Letter from FDA
MYOZYME® (2000 L) SUPPLY UPDATE_US VERSION_JANUARY 2009
Guidance to the Pompe Community on the
Genzyme Pompe Program Update- November 17, 2008
Myozyme Produced at the 2000 L Bioreactor Scale to Receive Accelerated Approval
Genzyme Program Update November 10th, 2008
Amicus Therapeutics Begins Phase 2 Clinical Trial of AT2220 in Pompe Disease
US Myozyme Manufacturing Update - April 2008
Genzyme Provides Update on Myozyme® Manufacturing
Amicus Therapeutics Presents Data from Clinical Ex Vivo Response Study 
January 2008 US Myozyme Supply Update*
Genzyme Study of Myozyme® for Late-Onset Pompe Patients Meets Co-Primary Efficacy Endpoints
Amicus Therapeutics and Shire plc Enter Into $440 Million ex-US Licensing Agreement
Amicus Therapeutics Announces Positive Results From Two Phase 1 Clinical Studies of
October Update on the US Myozyme® Supply
Rehabilitation Management of Pompe Disease 
JOINT LETTER FROM THE AMDA AND UPF
Therapy -- It's Here, and Free
US Myozyme® Supply Update July 25, 2007
MTAP Fact Sheet July 2007
GENZYME POMPE PROGRAM UPDATE JUNE 2007
MTAP FACT SHEET JUNE 2007
Pompe Program Update May 2007
Myozyme® Temporary Access Program
Flying with a ventilator in the USA
GENZYME POMPE PROGRAM APRIL 2007
Genzyme Update on the LOTS Trial- January 2007
AMICUS THERAPEUTICS COMMENCES PHASE 1 CLINICAL TRIALS FOR AT2220 FOR POMPE DISEASE 
The Myozyme Miracle 
FDA Approves Genzyme's Myozyme® for All Patients with Pompe Disease
European Commission Approves Genzyme's Myozyme® 
Expensive drug gives hope to rare disease sufferer
Genzyme Provides Update on U.S. Marketing Application for Myozyme®
Myozyme® Receives Positive Opinion from European Regulatory Committee
October 2005 Pompe Program Update
Genzyme Begins Trial of Myozyme® for Patients with Late-Onset Pompe Disease 
Genzyme Submits BLA for Myozyme® for Treatment of Pompe Disease
Pompe Program Update July 2005
Pompe Program Update March 2005 
Pompe Program Update December 2004 
Genzyme Files for European Approval of Myozyme For Treatment of Pompe Disease
IPA /Genzyme Joint Pompe Program Update, August 2004 
Genzyme Pompe Program Update May 2004
IPA Summary of Genzyme Press Release
Q AND A SESSION GENZYME IPA CONFERENCE NOVEMBER 2003
Genzyme Expands MyozymeTM 
IPA/GENZYME JOINT PROGRAM UPDATE
Genzyme Pompe Program Update February 18, 2003
Genzyme Pompe Program Update December 2002
IPA/Genzyme Meeting
Letter From Jan van Heek
Rescue of enzyme deficiency in embryonic diaphragm in a mouse
Long-Term Intravenous Treatment of Pompe Disease With Recombinant Human a-Glucosidase From Milk